Up-regulation of the chemokine CCL21 in the skin of subjects exposed to irritants.
BACKGROUND
Expression of murine CCL21 by dermal lymphatic endothelial cells (LEC) has been demonstrated to be one of the most important steps in Langerhans cell emigration from skin. Previously, our group and others have found that this chemokine is up-regulated in different human inflammatory skin diseases mediated by diverse specific immune responses. This study was carried out to investigate the involvement of CCL21 in human skin after challenge with irritant agents responsible for inducing Irritant Contact Dermatitis (ICD).


RESULTS
Eleven normal individuals were challenged with different chemical or physical irritants. Two patients with Allergic Contact Dermatitis (ACD) were also challenged with the relevant antigen in order to have a positive control for CCL21 expression. Macroscopic as well as microscopic responses were evaluated. We observed typical ICD responses with mostly mononuclear cells in perivascular areas, but a predominance of polymorphonuclear cells away from the inflamed blood vessels and in the epidermis at 24 hours. Immunohistochemical studies showed up-regulation of CCL21 by lymphatic endothelial cells in all the biopsies taken from ICD and ACD lesions compared to normal skin. Kinetic study at 10, 48, 96 and 168 hours after contact with a classical irritant (sodium lauryl sulphate) showed that the expression of CCL21 was increased in lymphatic vessels at 10 hours, peaked at 48 hours, and then gradually declined. There was a strong correlation between CCL21 expression and the macroscopic response (r = 0.69; p = 0.0008), but not between CCL21 and the number of infiltrating cells in the lesions.


CONCLUSIONS
These results provide new evidence for the role of CCL21 in inflammatory processes. Since the up-regulation of this chemokine was observed in ICD and ACD, it is tempting to speculate that this mechanism operates independently of the type of dermal insult, facilitating the emigration of CCR7+ cells.
Eberhard
Yanina
Y
Immunology, Department of Clinical Biochemistry, School of Chemical Science, National University of Cordoba, Argentina. yeberhard@bioclin.fcq.unc.edu.ar
Ortiz
Susana
S
Ruiz Lascano
Alejandro
A
Kuznitzky
Raquel
R
Serra
Horacio Marcelo
HM
D000328:Adult; D054421:Chemokine CCL21; D019742:Chemokines, CC / Q000032:analysis*; D017449:Dermatitis, Allergic Contact / Q000378:metabolism; D017453:Dermatitis, Irritant / Q000378:metabolism; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007509:Irritants / Q000276:immunology*; D042601:Lymphatic Vessels / Q000737:chemistry / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000737:chemistry* / Q000276:immunology; D015854:Up-Regulation
C515478:CCL21 protein, human; D054421:Chemokine CCL21; D019742:Chemokines, CC; D007509:Irritants